Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK1D | P48730 | 2/20 | 0.39 |
| ▸ | CSNK1G2 | P78368 | 1/20 | 0.39 |
| ▸ | KIF11 | P52732 | 1/20 | 0.36 |
| ▸ | G6PD | P11413 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.34 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.34 |
| ▸ | MIF | P14174 | 1/20 | 0.34 |
| ▸ | PPARA | Q07869 | 1/20 | 0.34 |
| ▸ | APP | P05067 | 3/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.32 |
| ▸ | CLK1 | P49759 | 1/20 | 0.30 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13730381 | 0.80 | ALDH1A1 (0.39) | CSNK1DCSNK1G2G6PDALDH1A1CYP2A6 | |
| SCHEMBL22857663 | 0.78 | BCL2L1 (0.40) | CYP2A6 | |
| SCHEMBL17340883 | 0.77 | CSNK1D (0.39) | CSNK1DCSNK1G2KIF11G6PDALDH1A1 | |
| SCHEMBL24617017 | 0.75 | CSNK1D (0.49) | CSNK1DCSNK1G2KIF11G6PDDYRK1A | |
| SCHEMBL549183 | 0.74 | G6PD (0.45) | G6PDALDH1A1CYP2A6DYRK1AMIF | |
| SCHEMBL17341212 | 0.74 | CYP2A6 (0.39) | G6PDALDH1A1CYP2A6DYRK1AMIF | |
| SCHEMBL19135535 | 0.74 | G6PD (0.35) | CSNK1DCSNK1G2G6PDALDH1A1CYP2A6 | |
| SCHEMBL4195351 | 0.73 | ENPP2 (0.38) | CSNK1DCSNK1G2G6PDALDH1A1CYP2A6 | |
| SCHEMBL29956540 | 0.73 | ENPP2 (0.38) | CSNK1DCSNK1G2G6PDALDH1A1CYP2A6 | |
| SCHEMBL18347531 | 0.73 | ALDH1A1 (0.48) | CSNK1DCSNK1G2G6PDALDH1A1CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9708528-B2 | Robust photochromic compounds with silicon- or phosphorus-containing heterocyclic ring and the production thereof | THE UNIVERSITY OF HONG KONG (HK) | 2017-07-18 | — | — | US | disclosed |
| US-20150361332-A1 | ROBUST PHOTOCHROMIC COMPOUNDS WITH SILICON- OR PHOSPHORUS-CONTAINING HETEROCYCLIC RING AND THE PRODUCTION THEREOF | THE UNIVERSITY OF HONG KONG (HK) | 2015-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150361332-A1 | ROBUST PHOTOCHROMIC COMPOUNDS WITH SILICON- OR PHOSPHORUS-CONTAINING HETEROCYCLIC RING AND THE PRODUCTION THEREOF | CRY1, CRY2, P2RY10 | CSNK1D 2378/4885CSNK1G2 2578/4885KIF11 3699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.